Lixte Biotechnology Holdings Inc — Quarterly Financial Statistics (NASDAQ:LIXT)

Financials

Cash from operating activities -957.6 K-598.67 K-568.48 K-487.49 K-926.75 K -2.58 M Cash from investing activities ————— — Cash from financing activities 00914.23 K-10 K5.56 M 6.47 M Free cash flow -957.6 K-598.67 K-568.48 K-487.49 K-926.75 K -2.58 M

뉴스

LIXTE Biotechnology appoints Sidney Braun to lead Liora subsidiary

LIXTE expands clinical trial for ovarian cancer treatment

스파르탄 캐피털, Lixte의 430만 달러 규모 유상증자 주선

Lixte Biotechnology stock falls after $4.3 million direct offering

Spartan Capital acts as placement agent in Lixte’s $4.3 million offering

릭스테 바이오, 430만 달러 규모 직접 공모 후 주가 하락

Lixte Biotechnology stock falls after $4.3 million direct offering

Lixte Biotechnology raises $4.3 million in registered direct offering

Lixte Biotechnology, 주주총회서 이사 선임 및 주식 계획 수정안 승인

Lixte Biotechnology shareholders approve board nominees and stock plan amendment

Lixte Biotechnology, 영국 Liora 인수 후 주가 하락

Lixte Biotechnology stock falls after acquiring UK-based Liora